Mark Kotter is a stem cell biologist and neurosurgeon at the University of Cambridge. Kotter is the founder and CEO of bit.bio, co-founder of the cultured meat startup Meatable and Myelopathy.org, a charity dedicated to common form of spinal cord injury. Focused on transitioning biology to engineering to address cancer and the consequences of poor health due to ageing.